Detalhe da pesquisa
1.
Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19.
Lung
; 201(2): 159-170, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37000214
2.
Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME.
Am J Respir Crit Care Med
; 199(1): 43-51, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30019939
3.
Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial.
Am J Respir Crit Care Med
; 198(3): 329-339, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29779416
4.
Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study.
Respir Res
; 19(1): 121, 2018 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29925383
5.
One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting ß2-agonist in UK primary care settings.
Respir Med
; 162: 105859, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31916534
6.
Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy Volunteers.
Clin Pharmacol Drug Dev
; 5(4): 306-13, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27310331
7.
Facial thermography is a sensitive tool to determine antihistaminic activity: comparison of levocetirizine and fexofenadine.
Br J Clin Pharmacol
; 62(2): 158-64, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16842390
8.
The Toll-like receptor-2/6 agonist macrophage-activating lipopeptide-2 cooperates with IFN-gamma to reverse the Th2 skew in an in vitro allergy model.
J Immunol
; 172(10): 6080-6, 2004 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15128792